1. Home
  2. |Insights
  3. |Consortium Awarded $30 Million for Manufacturing Pilot Program

Consortium Awarded $30 Million for Manufacturing Pilot Program

Client Alert | 1 min read | 08.23.12

On August 16, the Obama administration announced both a $30 million award  that may serve as a model for future partnerships geared towards manufacturing innovation to the National Additive Manufacturing Innovation Institute (NAMII) and a "pilot" program for the Administration's National Network of Manufacturing Innovation plan to invest $1 billion "to catalyze a national network of up to 15 manufacturing innovation institutes around the country." NAMII, which was selected in response to a Broad Agency Announcement solicitation, is a consortium including dozens of major government contractors and manufacturing firms, universities, and non-profit organizations which will "co-invest" $40 million to develop additive manufacturing technology (a process by which products and components are manufactured more efficiently using digital models).

Insights

Client Alert | 3 min read | 11.17.26

CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs

On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.  ...